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Abstract
Background: Overweight and obesity are associated with pregnancy complications and adverse perinatal
outcomes, posing short and long-term risks for maternal and child health. This study evaluated maternal, delivery
and neonatal outcomes in pregnancies complicated by overweight and obesity.
Methods: This prospective cross-sectional study included 258 pregnant women. According to prepregnancy body
mass index (BMI), participants were classified as normal weight, overweight, or obese. Data were analyzed using the
chi-square test and analysis of variance followed by the Tukey test. Logistic regression was performed to calculate
odds ratios and 95 % confidence intervals (p < 0.05).
Results: Most women ≥ 35 years old were overweight (22.7 %) and obese (27.6 %). Prepregnancy diabetes was
significantly associated with obesity (15.7 %, p < 0.000). Obese women showed the lowest weight gain (9.6 ± 7.5Kg).
Overweight and obese women practiced physical exercise more frequently (p = 0.010) than normal weight women.
A greater proportion of obese mothers (13.4 %) had large for gestational age babies (p = 0.021), with higher
thoracic circumference (33.6 ± 2.0 cm) and abdominal circumference (31.6 ± 2.3 cm). Obesity increased the risk
of developing hypertension (OR = 7.0; 3.1-15.9), hyperglycemic disturbances (OR = 5.5; 2.9-10.6) and HbA1c ≥ 6.
5 % (OR = 3.7; 1.2-11.1). The infants born to obese mothers had longer hospital stay (3.9 ± 3.9 days) (p = 0.005).
Conclusion: Our results confirm that obesity in pregnancy can lead to adverse outcomes, and underscore the
importance of identifying and treating inadequate weight status during pregnancy.
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Background
Overweight and obesity are defined as abnormal or
excess accumulation of adipose tissue in the body.
These conditions are caused by a combination of
genetic, metabolic, behavioral, environmental, cultural,
and socioeconomic factors. Overweight and obesity are
public health problems that contribute to preventable
deaths each year, and the number of overweight and
obese women at reproductive age is increasing in many
countries [1, 2].
Since pregnancy can serve as a triggering or aggravat-
ing factor for obesity [3, 4], diagnosing and monitoring
the weight status of pregnant women should be a rou-
tine prenatal care procedure [5, 6]. A number of factors,
such as water retention, uterine growth, formation of
fetal tissues and placenta, and increasing amniotic fluid
volume, can limit the evaluation of maternal body mass
index (BMI) during pregnancy [7, 8]. Therefore, since
2004, the Brazilian Ministry of Health has issued guide-
lines for categorizing ideal gestational weight gain based
on prepregnancy BMI. These guidelines, recommend
assessing a woman’s nutritional status during pregnancy
using a specific tool [6] which was developed based on
Atalah’s curve [9] and IOM recommendations [8].
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Overweight pregnant women have higher risks of
hypertension, gestational diabetes mellitus (GDM),
Cesarean section, shoulder dystocia and early neonatal
death [10–14]. Obesity in pregnancy compromises fetal
metabolic programming, increasing the risk of obesity,
diabetes and cardiovascular disorders in the offspring
[15, 16].
Thus, the present study aimed at evaluating maternal,
delivery and neonatal outcomes in pregnancies compli-
cated by overweight and obesity.
Methods
Study design and subjects
This is a prospective cross-sectional study including 258
pregnant women and their infants. Based on prepreg-
nancy weight as self-reported during the first prenatal
visit, pregnant women were classified according to BMI
as normal weight (18.5–24.9 Kg/m2 BMI; n = 65); over-
weight (25.0 - 29.9 Kg/m2 BMI; n = 66); or obese (BMI ≥
30.0 Kg/m2; n = 127) [17].
Ethics approval was granted by the Human Research
Ethics Committee of Botucatu Medical School-Unesp, and
written informed consent was obtained from all study
participants.
Inclusion and exclusion criteria
Inclusion criteria were prenatal care commencing up to
20 weeks of gestationand singleton pregnancy. Under-
weight pregnant women were excluded.
Data collection
During the first prenatal visit (before 20th gestational
week), the following maternal characteristics were eval-
uated: age (full years); number of gestations including
current pregnancy; previous Cesarean section; smoking
habits, history of hypertension and diabetes mellitu-
s,and family history of diabetes, obesity, hypertension,
cardiovascular disease and hypercholerestolemia. At the
end of gestation (37th to 38th gestational week), mater-
nal pregnancy outcomes were evaluated based on final
pregnancy weight; gestational weight gain; gestational
BMI; practice of light to moderate-intensity exercises
during pregnancy (yes or no); and intercurrent diseases
(such as urinary infection, genital infection, gestational
hypertension, preelampsia, hyperglycemic disorders
(mild gestational hyperglycemia – MGH, and gesta-
tional diabetes mellitus – GDM) [18, 19], and glycated
hemoglobin (HbA1c) levels in the third trimester of
pregnancy.
Data collected at birth included mode of delivery
(vaginal or C-section); gestational age; New Ballard
scores; birth weight; birth weight/gestational age category;
ponderal index [(birth weight/lenght3) × 100]; length;
circumference of the head, thorax, and abdomenl; 1, 5 and
10 min Apgar scores; placenta weight; and placental
index (PI = placenta weight/birth weight). In the cord
blood, the levels of glucose, hematocrit, hemoglobin,
bilirubin, and white and red blood cells were evalua-
ted.During the neonatal period, information on
hypoglycemia episodes; need for phototherapy; malfor-
mations and infant hospital stay length was obtaine-
d.All data were recorded on forms specifically
developed for the study.
Follow-up
All women received follow up care at the Diabetes and
Pregnancy Referral Center of Botucatu Medical School-
Unesp. Reasons for referral were previous diabetes mel-
litus (type 1-DM or type 2-DM) or risk of developing
hyperglycemic disorders [20], i.e. gestational diabetes
mellitus (GDM) and mild gestational hyperglycemia
(MGH) [17, 19].
According to our center’s routine protocol [18, 19],
diabetic pregnant women (type 1-DM or type 2-DM)
were immediately managed with glycemic control, individ-
ualized nutritional intervention, and a light to moderate-
intensity exercise program (most frequently walking for
30 minutes five times a week). Insulin therapy was intro-
duced when necessary [21].
Pregnant women who were nondiabetic, but were
overweight or obese, were advised as to the importance
of lifestyle changes to prevent GDM and MGH, and
were promptly assigned to individualized nutritional
guidance and home walking for 30 minutes five times a
week for weight control during pregnancy. Regardless of
these preventive measures, all nondiabetic pregnant
women underwent glucose tolerance (75 g-OGTT) and
gycemic profile (GP) testing between 24 and 28 weeks of
pregnancy for confirmation or ruling out of GDM and
MGH [18–20]. Pregnant women with confirmed GDM
or MGH were treated according to the same protocol to
achieve glycemic control. Insulin therapy was introduced
when necessary. Glycemic control and management of
diabetes were evaluated by 24-h GP (fasting, pre- and
post- prandial glycemic levels) performed at 2-week in-
tervals until week 32, and weekly until delivery [18–20].
Statistical analyses
Data were systematically transferred from medical re-
cords to Microsoft Excel 2010. Statistical analyses were
performed using SAS 9.2 for Windows. Data frequencies
(in percentage) were compared using the chi-square test;
means were evaluated by analysis of variance (ANOVA),
followed by the Tukey-Kramer test for multiple compari-
sons. Data on maternal, neonatal and delivery outcomes
were assessed using logistic regression to calculate odds
ratios with confidence intervals (CI 95 %). Significance
level was set at p < 0.05.
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Results
Overweight and obesity predominated among pregnant
women ≥ 35 years, whereas normal weight was most fre-
quently observed among pregnant adolescents (≤19 years
old) (p < 0.001). Prepregnancy diabetes was more fre-
quent in obese (15.7 %) and overweight (13.6 %) women
than in women with normal weight (6.2 %). The preva-
lence of of family history of obesity was greater in obese
and overweight women, although not statistically signifi-
cant (p = 0.051) (Table 1).
Compared to women with normal weight, overweight
and obese women showed higher mean baseline weight
and final weight, prepregnancy BMI and gestational BMI
(at 37–38 weeks of pregnancy) (p < 0.001). Nonetheless,
weight gain (WG) was lowest in the obese group
(Table 2).
WG < 8 Kg was more frequent among the obese,
while excess WG (WG > 16 kg) was more frequently
seen in women with normal weight (p < 0.001). By the
end of pregnancy, most normal weight women were ei-
ther overweight (35.4 %) or obese (3.1 %) (p < 0.001).
Most overweight and obese women engaged in physical
activity during pregnancy (p = 0.010), and developed ei-
ther GDM (p < 0.001) or MGH (p = 0.005). Irrespective
of group, over 80.0 % of the pregnant women with
hyperglycemia exhibited normal HbA1c levels (<6.5 %)
in the third trimester of pregnancy, with no differences
among groups (p = 0.075) (Table 2).
Obese women had the highest rate of LGA (13.4 %)
and the lowest rate of SGA infants (4.7 %) (p = 0.021);
with 40.9 % of these infants showing disproportionate
growth (IP ≥ 2.98) (p = 0.037). Mean thoracic circumfer-
ence (p = 0.006), abdominal circumference (p = 0.032),
placental weight (p < 0.001) and placental index (p = 0.037)
were higher in the obese group (Table 3). The infants
born to obese mothers remained in hospital for a lon-
ger period (p = 0.005), but maternal weight status did
not affect neonatal outcomes (Table 4).
Compared to normal weight women, obese and over-
weight mothers had lower weight gain (WG), with odds
ratio (OR) of 0.2 (0.1–0.4) and 0.4 (0.2–0.7), respect-
ively. This indicates that overweight and obesity were
protective against excess maternal weight gain. Never-
theless, obese women showed higher risk of developing








N (%) N (%) N (%)
Age (years)* <0.001
≤19 12 (18.5) 2 (3.0)a 1 (0.8)a
20 – 35 46 (70.8) 49 (74.2) 91(71.6)
>35 7 (10.8) 15 (22.7)a 35 (27.6)a
Pregnancies (including current pregnancy) 0.187
1 18 (27.7) 11 (16.7) 19 (15.0)
2 19 (29.2) 18 (27.3) 33 (26.0)
≥3 28 (43.1) 37 (56.1) 75 (59.6)
Previous C-section 0.366
Zero 44 (67.7) 35 (53.0) 68 (53.5)
1 14 (21.5) 20 (30.3) 36 (28.4)
≥2 7(10.8) 11 (16.7) 23 (18.1)
Smoking habits 9 (13.8) 17 (25.8) 20 (15.8) 0.141
Cronic hypertension 4 (50.0) 17 (81.0) 47 (74.6) 0.231
Prepregnancy diabetes 4 (6.2) 9 (13.6)a 20 (15.7)a <0.001
Family history
Diabetes 54 (83.1) 48 (72.7) 93 (73.2) 0.266
Obesity 17 (26.2) 24 (36.4) 56 (44.1)a,b 0.051
Hypertension 44 (67.7) 49 (74.2) 101 (79.5) 0.195
Cardiovascular disease 14 (21.5) 19 (28.8) 43 (33.9) 0.206
Hypercholesterolemia 15 (23.1) 20 (30.3) 41 (32.3) 0.410
* Chi-square test
a statistically different from the control group (p < 0.05)
b statistically different from the overweight group (p < 0.05)
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hypertension (OR = 7.0; 3.1–15.9), hyperglycemic distur-
bances (OR = 5.5; 2.9–10.6) and HbA1c > 6.5 % (OR = 3.7;
1.2–11.1) during pregnancy. Maternal weight status did
not affect neonatal outcomes (Table 5).
Discussion
In the present study, overweight and obesity were associ-
ated with increased maternal weight, and gestational
BMI, as well as higher prevalence of GDM and MGH. In
the obese group, the proportion of LGA babies with dis-
proportionate ponderal index (≥2.98), placenta weight
and placental index (PI) were higher, and hospitalstay
length was longer. Obesity was associated with higher
risk of developing hypertension, hyperglycemia and
HbA1c ≥ 6.5 % in late pregnancy. Unexpectedly, obesity
and overweight were protective factors against maternal
weight gain, without affecting neonatal outcomes.
Obese and overweight women were heavier and showed
higher prepregnancy BMI, which was proportional to their
nutritional status. These features persisted throughout
pregnancy and were associated with hypertension, GDM
and MGH. Similar results have also been observed in
previous studies showing association of increased BMI
with development of hypertension and hyperglycemia
[3, 7, 22–24].
In this study, logistic regression analysis indicated
obesity as a risk factor for gestational hypertension and
hyperglycemia, increasing the likelihood of their occur-
rence seven and five-fold, respectively. This maternal
characteristic was also a determining factor for the four-
fold increase in the occurrence of HbA1c ≥ 6.5 % at the








Mean ± sd Mean ± sd Mean ± sd
Initial weight (Kg) 57.1 ± 5.7 69.9 ± 6.7a 91.2 ± 13.7a,b <0.001
Final weight (Kg) 71.5 ± 7.1 82.9 ± 7.6a 100.7 ± 15.4a,b <0.001
Weight gain (Kg) 14.4 ± 4.6 12.8 ± 5.7 9.6 ± 7.5a,b <0.001
Prepregnancy BMI (Kg/m2) 22.4 ± 1.7 27.5 ± 1.3a 36.2 ± 4.9a,b <0.001
Gestational BMI (Kg/m2) 28.1 ± 2.4 32.6 ± 2.7a 39.9 ± 5.5a,b <0.001
N (%) N (%) N (%) †p-value
Weight gain (Kg) <0.001
<8 5 (7.8) 12 (18.2) 58 (45.7)a,b
8 – 16 36 (55.4) 36 (54.6) 42 (33.1)a,b
>16 24 (36.9) 18 (27.3) 27 (21.3)
Gestational BMI (Kg/m2) <0.001
Underweight 7 (10.8) 0 (0.0)a 0 (0.0)a
Adequate 33 (50.8) 5 (7.6)a 0 (0.0)a,b
Overweight 23 (35.4) 35 (53.0)a 8 (6.3)a,b
Obese 2 (3.1) 26 (39.4)a 119 (93.7)a,b
Physical activity (yes) 17 (26.2) 34 (51.5)a 55 (43.3)a 0.010
Intercurrent diseases 30 (46.2) 26 (39.4) 62 (48.8) 0.458
Urinary infection 8 (12.5) 8 (11.9) 30 (23.6)
Genital infection 12 (18.8) 12 (17.9) 15 (11.8)
GH or PE 4 (50.0) 4 (19.0) 16 (25.4)
GDM 8 (12.3) 22 (33.3)a 50 (39.4)a <0.001
MGH 12 (18.4) 15 (22.7)a 27 (21.2)a 0.005
HbA1c (%) [3rd trimester] 0.075
<6.5 61 (93.8) 53 (80.3) 102 (80.3)
6.5 – 8.0 3 (4.6) 13 (19.7) 23 (18.1)
≥8.0 1 (1.6) 0 (0.00) 2 (1.57)
* ANOVA; Tukey test
† Chi-square test
a statistically different from the control group (p < 0.05)
b statistically different from the overweight group (p < 0.05)
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end of pregnancy. Hypertension and hyperglycemia asso-
ciated with central obesity (in women, BMI ≥ 30 Kg/m2
or waist circumference ≥ 80 cm) are clinical criteria for
the diagnosis of metabolic syndrome (MS), whose phys-
iopathological basis is the association between obesity
and insulin resistance [25].
Insulin resistance, classically considered as a charac-
teristic of healthy pregnancy, is more pronounced in
pregnancies complicated by diabetes [26]. The relation-
ship between maternal MS and hyperglycemia during
pregnancy was first reported by Bo et al. [27] and has been
recently corroborated by our research group [28, 29].
Table 3 Delivery and neonatal outcomes
Normal weight Overweight Obese *p-value
N = 65 N = 66 N = 127
N (%) N (%) N (%)
Mode of delivery 0.304
Vaginal 25 (39.5) 21 (31.8) 35 (27.6)
Cesarean 40 (61.5) 45 (68.2) 92 (72.4)
Gestational age (weeks) 0.494
<37 3 (4.6) 5 (7.6) 12 (9.4)
≥37 62 (95.4) 61 (92.4) 115 (90.6)
New Ballard (weeks)± 0.115
<37 3 (5.8) 6 (10.9) 19 (17.1)
≥37 49 (94.2) 49 (89.1) 92 (82.9)
Birth weight (g) 0.304
<2500 4 (6.2) 2 (3,0) 2 (1.6)
2500 − 4000 57 (87.7) 61 (92.4) 113 (89.0)
≥4000 4 (6.2) 3 (4.6) 12 (9.4)
Weight class 0.021
SGA 8 (12.3) 10 (15,2) 6 (4.7)a,b
AGA 54 (83.1) 53 (80.3) 104 (81.9)
LGA 3 (4.6) 3 (4.6) 17 (13.4)
Ponderal index (PI) 0.037
<2.98 (proportional) 50 (76.9) 46 (69,7) 75 (59.1)
≥2.98 (disproportionate) 15 (23.1) 20 (30.3) 52 (40.9)a,b
Mean ± sd Mean ± sd Mean ± sd #p-value
Weight (g) 3210.2 ± 469.2 3208.9 ± 430.4 3365.9 ± 483.4 0.199
Length (cm) 48.6 ± 2.2 48.4 ± 2,0 48.6 ± 2.1 0.759
Head Circumf (cm) 34.4 ± 1.5 34.4 ± 1,3 34.8 ± 1.5 0.094
Thoracic Circumf (cm) 32.9 ± 1.9 32.8 ± 1,7 33.6 ± 2.0a,b 0.006
Abdom Circumf (cm) 31.1 ± 2.3 30.7 ± 1,8 31.6 ± 2.3a,b 0.032
1-min Apgar 8.3 ± 1.4 8.2 ± 1,8 7.8 ± 1.5 0.076
5-min Apgar 9.3 ± 0.8 9.3 ± 0.9 9.1 ± 0.8 0.143
10-min Apgar 9.7 ± 0.5 9.6 ± 0.6 9.5 ± 0.6 0.071
Ponderal index 2.8 ± 0.3 2.8 ± 0.3 2.9 ± 0.3a,b 0.005
Placental weight (g) 560.1 ± 138,9 574,6 ± 119,8 635,6 ± 156,6a,b 0.001
Placental index 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0a,b 0.037
± N = 217 [41 newborns with incomplete data]
* Chi-square test
# ANOVA; Tukey test
a statistically different from the control group p < 0.05)
b statistically different from the overweight group (p < 0.05)
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Thus, in addition to the 13–15 % rates of pregestational
DM observed in the present study, the overweight and
obese groups were expected to show elevated rates of
MGH or GDM, and a high proportion of HbA1c ≥ 6.5 %.
However, although elevated rates of MGH (about 22 %)
and GDM (approximately 30 to 40 %) were indeed ob-
served, only 20.0 % of the overweight and obese partici-
pants showed HbA1c ≥ 6.5 %.
All overweight and obese women participating in this
study received individualized dietary advice and were
encouraged to engage in physical activity regardless of
diagnosis of diabetes or hyperglycemia. Indeed, 51.5 and
43.3 % of overweight and obese pregnant women, respect-
ively, adhered to physical activity recommendations, but
these measures did not prevent the occurrence of MGH
or GDM, probably because the period between admission
and diagnostic testing for MGH/GDM was short (about
four weeks). Nonetheless, there was a 60–70 % reduction
in the risk of excessive weight gain, which may have con-
tributed to the lower weight gain observed in the obese
group, as well as to the significant rates of overweight and
obese women (35 to 40 %) moving to lower BMI classes
in late pregnancy, and the achievement of maternal
hyperglycemia control (HbA1c levels < 6.5 %) in 80 % of
overweight and obese women.
The relationship of diet/exercise with maternal weight
remains controversial. Several studies have evaluated the
effects of dietary advice alone or associated with exer-
cise, on maternal weight gain, but no consistent results
have been obtained [30–33]. A recent meta-analysis has
suggested that compared to unsupervised physical ac-
tivity and diet interventions, supervised exercise plus
diet programs were most effective in managing weight
among overweight or obese pregnant and postpartum
women [34].
In this study, LGA infants, with PI ≥ 2.98 and higher
thoracic and abdominal circumference measures, as well
as increased placental weight and placental índex were
more frequent in the obese group. According to previ-
ous studies, gestational BMI and DM or hyperglycemia
are independent risk factors for excessive fetal growth
[7, 12, 35, 36]. Moreover, macrosomia, disproportionate
growth, placentomegaly, high placental index, and in-
creased fetal measures (especially abdominal circumfer-
ence) have been considered common features in babies
born to diabetic mothers [19, 20, 35]. In Brazil, a recent








N (%) N (%) N (%)
Hypoglycemia 0 0 1 (1.0) 0.620
Malformation 2 (4.4) 2 (4.0) 6 q 0.833
Phototherapy 14 (23.0) 10 (16.4) 37 (37.0) 0.091
Mean ± SD Mean ± SD Mean ± SD #p-value
Hematocrit (%) 48.3 ± 5.3 51.0 ± 9.3 49.6 ± 5.4 0.163
Hemoglobin (g/dL) 16.2 ± 1.8 16.4 ± 1.9 16.3 ± 2.4 0.832
Ind. Bilirubin (mg/dL) 1.9 ± 0.5 2.0 ± 0.7 2.0 ± 0.6 0.575
White cells (x103/mm3) 14755 ± 3095.8 14786 ± 6627.7 14543 ± 4332.8 0.975
Red cells (/mm3) 4.8 ± 0.6 4.4 ± 0. 5 4.6 ± 0.5 0.082
Glucose levels (mg/dL) 63.4 ± 16.3 65.8 ± 25.5 66.0 ± 20.5 0.091
Hospitalization (days) 3.0 ± 1.5 3.0 ± 1.4 3.9 ± 3.9a,b 0.005
± N = 204 [54 infants with incomplete records]
* Chi-square test
# ANOVA; Tukey test
a statistically different from the control group (p < 0.05)
b statistically different from the overweight group (p < 0.05)
Table 5 Odds ratio (OR) and confidence interval (CI 95 %) of





OR CI 95 % OR CI 95 %
Mother
Weight gain≥ 16 Kg 0.2 0.1 – 0.4 0.4 0.2 − 0.7
Hypertension 7.0 3.1 − 15.9 2.1 1.1 − 3.9
Hyperglycemia 5.5 2.9 – 10.6 1.3 0.7 – 2.6
HbA1c≥ 6.5 % 3.7 1.2 – 11.1 1.0 0.5 – 2.2
Newborn
Weight 2.3 0.8 – 6.6 1.9 0.7 – 5.4
Weight classes 1.0 0.4 – 2.1 0.8 0.4 – 1.7
1-min Apgar score 0.4 0.1 – 1.1 0.6 0.2 – 1.5
5-min Apgar score 2.0 0.1 – 32.0 1.9 0.1 – 31.5
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review has shown that a large proportion of women are
overweight or obese at the beginning of pregnancy, and
that this is associated with higher risk of excessive weight
gain, cesarean delivery, and fetal macrosomia [37].
In our study, overweight and obesity were identified
as preventive factors against excessive weight gain
without risk for the baby. Thus, the adverse neonatal
outcomes here observed were probably caused by mater-
nal hyperglycemia. Previous results obtained by our re-
search group show that fetal macrosomia is significantly
associated with prepregnancy BMI, hyperglycemic levels,
and personal history of macrosomia in pregnancies com-
plicated by diabetes or mild hyperglycemia [38]. A cohort
study of 6,125 deliveries, using logistic multivariate
analysis to exclude potential confounding variables, has
demonstrated that only neonatal macrosomia and meco-
nium aspiration syndrome remain significantly associated
with maternal overweight and obesity [39]. Macrosomia
and excessive fetal growth are frequently associated with
BMI ≥ 25 kg/m2 and maternal diabetes or hyperglycemia,
which are also interdependent. Therefore, it is practically
impossible to determine the intensity of such effects.
Although indirectly, our results corroborate the useful-
ness of dietary advice plus exercise as a preventive inter-
vention against excessive weight gain in pregnancies
complicated by overweight or obesity. However, this
study has some limitations that include the adoption of
a cross-sectional rather than a randomized controlled
design, the potential bias of confounding factors relative
to missing personal information (pre-gestational weight,
compliance to treatment protocol); and sample size,
which might not have been large enough for the evalu-
ation of neonatal outcomes and a more elaborate statis-
tical analysis (adjustment for age, parity and maternal
weight or multiple regression analysis).
Conclusions
In the present study, adverse pregnancy outcomes were as-
sociated with obesity and overweight, and indirectly related
to maternal hyperglycemia. Obesity was a determinant risk
factor for hypertension, hyperglycemia, and increased
HbA1c levels at the end of pregnancy. Overweight elevated
the risk of hypertension, and both obesity and overweight
were protective factors against excessive maternal weight
gain without affecting neonatal outcomes. These findings
indicate that adverse outcomes resulted from inadequate
nutritional status during pregnancy, and indirectly under-
score the importance of identifying and treating inadequate
weight status during pregnancy.
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